Dual antiplatelet therapy in recurrent stroke prevention: Do the benefits outweigh the risks?

Muhammad U. Farooq; Philip B. Gorelick

doi:10.1136/eb-2013-101642

Dual antiplatelet therapy in recurrent stroke prevention: Do the benefits outweigh the risks?

Muhammad U. Farooq^*, Philip B. Gorelick

^*Corresponding author for this work

Neurology

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	137
Number of pages	1
Journal	Evidence-Based Medicine
Volume	19
Issue number	4
DOIs	https://doi.org/10.1136/eb-2013-101642
State	Published - Aug 2014

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1136/eb-2013-101642

Cite this

@article{85b6156644714eb2b387d352edceaba8,

title = "Dual antiplatelet therapy in recurrent stroke prevention: Do the benefits outweigh the risks?",

author = "Farooq, {Muhammad U.} and Gorelick, {Philip B.}",

year = "2014",

month = aug,

doi = "10.1136/eb-2013-101642",

language = "English (US)",

volume = "19",

pages = "137",

journal = "Evidence-Based Medicine",

issn = "1356-5524",

publisher = "BMJ Publishing Group",

number = "4",

}

TY - JOUR

T1 - Dual antiplatelet therapy in recurrent stroke prevention

T2 - Do the benefits outweigh the risks?

AU - Farooq, Muhammad U.

AU - Gorelick, Philip B.

PY - 2014/8

Y1 - 2014/8

UR - http://www.scopus.com/inward/record.url?scp=84905820947&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905820947&partnerID=8YFLogxK

U2 - 10.1136/eb-2013-101642

DO - 10.1136/eb-2013-101642

M3 - Comment/debate

C2 - 24520127

AN - SCOPUS:84905820947

SN - 1356-5524

VL - 19

SP - 137

JO - Evidence-Based Medicine

JF - Evidence-Based Medicine

IS - 4

ER -

Dual antiplatelet therapy in recurrent stroke prevention: Do the benefits outweigh the risks?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this